Skip to main content

Anti-Rheumatic Rx

    Rheumatology Roundup
    Drs. Jack Cush and Arthur Kavanaugh discuss highlights and key takeaways from ACR 23. This included the following abstracts: 0025 Cannibinoids & pain 1584 TMP/SMX in GPA 0607 CAR-T cells in…
    Daily Recap - WEDNESDAY
    As per #ACR23 ABST0433, what % of RA patients on US Medicare are on a DMARD within 1y of diagnosis?

    I'm not talking you
    6 months 1 week ago
    As per #ACR23 ABST0433, what % of RA patients on US Medicare are on a DMARD within 1y of diagnosis? I'm not talking your choice of b/tsDMARD. I'm talking any cs/b/tsDMARD of any sort. Hear from @JihaRheum to skip to the answer: https://t.co/lI2M20JWKC Truly stunning. @RheumNow
    We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for nearly 3 years, but prior to ACR Convergence 2023 there has been relatively little to say about…
    #ACRbest Yrin Preview @ACRheum
    J Bathon

    Take home
    Symptomatic #Rx of ACPA+ people WITH #DMARD is too late to alter risk
    6 months 1 week ago
    #ACRbest Yrin Preview @ACRheum J Bathon Take home Symptomatic #Rx of ACPA+ people WITH #DMARD is too late to alter risk of #RA when drug is d/c AI to read joint erosions on X-ray May be ‘too little too late’ #Steroids in #RA increase #MACE even after d/c #ACR23 @RheumNow
    Peng et al. 146 IgG4-RD in remission on immunomodulators+GC. 18 month follow-up. Withdraw IM+GC - 52% flare. Withdraw GC
    6 months 1 week ago
    Peng et al. 146 IgG4-RD in remission on immunomodulators+GC. 18 month follow-up. Withdraw IM+GC - 52% flare. Withdraw GC + continue IM 14.2% flare. Continue both 12.2% flare. Clear message that ongoing IM is the way Abstr#L16 #ACR23 #ACRbest @RheumNow https://t.co/3CAQhyTYqq https://t.co/qr1GOSvJYg
    L16 #ACR23 @RheumNow
    W/d of Immunosuppr and Low-dose steroid in IgG4RD
    Gr1: W/d GC+IM, G2: IM alone, G3: Maintain
    Relaps
    6 months 1 week ago
    L16 #ACR23 @RheumNow W/d of Immunosuppr and Low-dose steroid in IgG4RD Gr1: W/d GC+IM, G2: IM alone, G3: Maintain Relapse rate: G1 52%, G2 14%, G3 12% https://t.co/xe6NLVxUov
    Withdrawing immunosuppression and steroids in IgG4-RD

    Maintaining immunosuppression with or without steroids associate
    6 months 1 week ago
    Withdrawing immunosuppression and steroids in IgG4-RD Maintaining immunosuppression with or without steroids associated with low relapse rate 52% of pts who withdrew steroids +immunosuppression relapsed @RheumNow #ACR23 Abs#L16 https://t.co/xJyDiCkMVD
    Withdrawal of Immunosuppressant and Low-dose Steroids in IgG4-RD Patients with Stable Disease
    146 pts - 3 Grps
    1: withd
    6 months 1 week ago
    Withdrawal of Immunosuppressant and Low-dose Steroids in IgG4-RD Patients with Stable Disease 146 pts - 3 Grps 1: withdraw GC+IM 2:withdraw GC but maintain IM; 3: maintain GC+IM The maintenance of IMs, with or without low-dose GC, superior to withdraw #ACR23 @rheumnow #abstL16